Formulari Ubat KKM (FUKKM)

# Generic Name MDC Category Indications Dosage
1591 Travoprost 0.004% & Timolol 0.5% Eye Drops S01ED51990D2003XX A* To decrease intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to other topical anti glaucomas 1 drop in the affected eye(s) once daily
1592 Tretinoin 0.01% Gel D10AD01000G3001XX A/KK Acne vulgaris, recalcitrant cases of acne (comedonal type) Apply thinly to the affected area once daily or twice daily. Avoid exposure to sunlight. Duration of treatment: 8-12 weeks is required before any noticeable response
1593 Tretinoin 0.05% Cream D10AD01000G1001XX A/KK Acne vulgaris and recalcitrant cases of acne (comedonal type) Apply thinly to the affected area once daily or twice daily. Avoid exposure to sunlight. Duration of treatment: 8 - 12 weeks is required before any noticeable response
1594 Tretinoin 0.1% Cream D10AD01000G1002XX A Acne vulgaris and recalcitrant cases of acne (comedonal type) Apply thinly to the affected area once daily or twice daily. Avoid exposure to sunlight. Duration of treatment: 8 - 12 weeks is required before any noticeable response
1595 Triamcinolone Acetonide 0.1% Oral Paste A01AC01351G3101XX B Oral and perioral lesions Apply a thin layer to affected area 2-4 times daily
1596 Triamcinolone Acetonide 10 mg/ml Injection H02AB08351P3001XX A Inflammation of joints, bursae and tendon sheaths Smaller joints: 2.5 - 5 mg and larger joints: 5 - 15 mg. Treatment should be limited to 1 mg/injection site to prevent cutaneous atrophy
1597 Triamcinolone Acetonide 40 mg/ml Injection H02AB08351P3002XX A/KK Allergies, dermatoses, rheumatoid arthritis and inflammatory opthalmic diseases 40-80 mg deep into the gluteal muscle
1598 Trifluoperazine HCI 5 mg Tablet N05AB06110T1001XX B Psychotic disorder ADULT: Initially 5 mg twice daily, increase by 5 mg after 1 week, then at 3-day intervals. Maximum 40 mg/day. CHILD up to 12 years: Initially up to 5 mg daily in divided doses adjusted to response, age and body weight
1599 Trimetazidine 20 mg Tablet C01EB15110T1001XX B Prophylactic treatment of episodes of angina pectoris 20 mg 3 times daily
1600 Trimetazidine 35 mg MR Tablet C01EB15110T5001XX B Prophylactic treatment of episodes of angina pectoris 35 mg twice daily in the morning and evening with meals
1601 Trimethoprim 100 mg Tablet J01EA01000T1001XX B Treatment of urinary tract infections due to susceptible pathogens ADULT: 200 mg daily in 1 or 2 divided doses or 300 mg daily as a single dose. Acute infection: 200 mg twice daily. CHILD: 6-8 mg/kg/day in 2 divided doses. 6 - 12 years: 100 mg twice daily; 6 months - 5 years: 50 mg twice daily. 6 weeks - 5 months: 25mg twice daily
1602 Trimethoprim 300 mg Tablet J01EA01000T1002XX B Treatment of urinary tract infections due to susceptible pathogens ADULT: 200 mg daily in 1 or 2 divided doses or 300 mg daily as a single dose. Acute infection: 200 mg twice daily. CHILD: 6 - 12 years: 100 mg twice daily; 6 months - 5 years: 50 mg twice daily. 6 weeks - 5 months: 25mg twice daily
1603 Trioxsalen 5 mg Tablet D05BA01000T1001XX A Vitiligo 5 - 10 mg daily, 2 - 4 hours before exposure to sunlight. To increase pigmentation: 10 mg daily, 2 hours prior to UV irradiation
1604 Triprolidine HCl 1.25 mg and Pseudoephedrine HCl 30 mg per 5 ml Syrup R01BA52110L9001XX B Decongestion of the upper respiratory tract in common cold, hay fever, allergic and vasomotor rhinitis and sinusitis. Doses to be taken twice daily or three times daily ADULT and CHILD more than 12 year : 10 ml. CHILD 6 - 12 years : 5 ml 2 - 5 years : 2.5 ml
1605 Triprolidine HCl 2.5 mg and Pseudoephedrine HCl 60 mg Tablet R01BA52988T1002XX B Decongestion of the upper respiratory tract in common cold, hay fever, allergic and vasomotor rhinitis and aerotitis ADULT 2.5 mg every 4 - 6 hours; maximum dose 10 mg/day. CHILD (syrup) 6 - 12 years : 1.25 mg every 4 - 6 hours; maximum dose 5 mg/day 4 - 6 years : 0.938 mg every 4 - 6 hours; maximum dose 3.744 mg/day 2 - 4 years : 0.625 mg every 4 - 6 hours; maximum dose 2.5 mg/day
1606 Triptorelin 3.75 mg Injection L02AE04000P2001XX A i) Treatment of confirmed central precocious puberty (preterm sexual development) in girls under 9 years, boys under 10 years of age ii) Genital and extragenital endometriosis (stage I to stage IV). Treatment should not be administered for more than 6 months. It is not recommended to start a second treatment course with triptorelin or another GnRH analogue. 1 intramuscular injection every 4 weeks. The treatment must be started in the first 5 days of the menstrual cycle. The duration of treatment depends on the initial severity of the endometriosis and the changes observed in the clinical features. In principle, the treatment should be administered for at least 4 months and for at most 6 months. It is not recommended to start a second treatment course with triptorelin or another GnRH analogue.
1607 Tropicamide 1% Eye Drops S01FA06000D2002XX A/KK Topical use to produce cycloplegic refraction for diagnostic purposes 1 - 2 drops several times a day
1608 Trospium Chloride 20mg coated tablet G04BD09100C1001XX A* Symptomatic treatment for urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder (eg. Idiopathic or neurologic detrusor overactivity) Place in therapy: As first line treatment for overactive bladder in patients with Parkinsonism, Alzheimer?s or other cognitive disease 1 tablet twice daily. Tablet should be swallowed whole with a glass of water before meals on empty stomach. Severe renal impairment (CrCl between 10 & 30 mL/min/1.73 m2): 1 tab daily or every other day
1609 Tuberculine PPD Injection V04CF01000P3001XX B For routine Mantoux (tuberculin sensitivity) test 10 units is injected intradermally
1610 Typhoid Vaccine Capsule J07AP01000C1001XX B Active immunization against typhoid fever in adult and child 6 years of age or older ADULT and CHILD 6 years of age or older, 1 capsule on days 1, 3 and 5
1611 Typhoid Vaccine Injection (20 doses) J07AP02000P3001XX B Active immunization against typhoid fever in adult and child more than 2 years 0.5 ml single IM injection into the deltoid or vastus lateralis, may reimmunize with 0.5 ml IM every 3 years if needed.
1612 Ulipristal Acetate 30mg Tablet G03AD02122T1001XX A Emergency contraception within 4-5 days of unprotected sexual intercourse for sexual assault victim. Dosage is one tablet to be taken orally as soon as possible, but no later than 120 hours (5 days) after unprotected sexual intercourse or contraceptive failure.
1613 Umeclidinium 62.5 mcg and Vilanterol 25mcg inhalation R03AL03989A2001XXX A* Indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). One inhalation daily
1614 Urofollitropin (FSH) 150 IU Injection G03GA04000P3002XX A* Stimulation of follicular growth in infertile women To be individualized. 75 IU-150 IU daily and maybe increased or decreased by up to 75 IU/day at 7 or 14 day intervals if necessary
1615 Urofollitropin (FSH) 75 IU Injection G03GA04000P3001XX A* Stimulation of follicular growth in infertile women To be individualized. 75 IU-150 IU daily and maybe increased or decreased by up to 75 IU/day at 7 or 14 day intervals if necessary
1616 Urokinase 250,000 IU Injection B01AD04-000-P40-04-XXX A Treatment of thromboembolic disease such as mycocardial infarction, peripheral artery occlusion, pulmonary embolism, retinal artery thrombosis and other ophthalmologic use ADULT: Acute pulmonary embolism: IV loading dose 4400 iu/kg over 10 mins, maintenance 4400 iu/kg/hour for 12 hours. Peripheral vascular occlusion: infuse 2500 iu/ml into clot at a rate of 4000 iu/min for 2 hours. This may be repeated up to 4 times. Hyphaema: 5000 IU in 2 ml saline solution is injected and withdrawn repeatedly over the iris. If residual clot remains, leave 0.3ml in the anterior chambers for 24-48 hours to facilitate futher dissolution
1617 Ursodeoxycholic Acid 250 mg Capsule A05AA02000C1001XX A Cholestatic liver diseases (eg. primary biliary cirrhosis, primary cholangitis etc) 10-15 mg/kg daily in 2 to 4 divided doses usually for 3 months to 2 years. If there is no decrease in stone size after 18 months, further treatment seems not to be useful
1618 Ustekinumab 90 mg/ml Injection L04AC05000P3002XX A* Treatment of moderate to severe plaque psoriasis in adults who failed to, or who have contraindication to, or are intolerant to conventional systemic therapies including ciclosporin, methotrexate and photochemotherapy (PUVA). Body weight less than 100kg: Initial dose of 45 mg SC, followed by 45 mg 4 weeks later, then every 12 weeks thereafter. Body weight more than 100 kg: initial dose 90 mg SC, followed by 90 mg 4 weeks later, & then every 12 weeks thereafter.
1619 Valganciclovir 450 mg Tablet J05AB14110T1001XX A* For the prevention of cytomegalovirus (CMV) disease in CMV-negative patients who have received a solid organ transplant from a CMV-positive donor For adult patients who have received other than kidney transplant, the recommended dose is 900 mg (two 450 mg tablets) once a day starting within 10 days of transplantation until 100 days post-transplantation. For adult patients who have received a kidney transplant, the recommended dose is 900 mg (two 450 mg tablets) once a day starting within 10 days of transplantation until 200 days post-transplantation.
1620 Valproic Acid and Sodium Valproate (ER) 500mg Tablet N03AG01520T5001XX B i) In the treatment of generalized or partial epilepsy, particularly with the following patterns of seizures:absence, myoclonic, tonic-clonic, atonic-mixed as well as, for partial epilepsy:simple or complex seizures, secondary generalized seizures, specific syndrome (West, Lennox-Gastatut). ii) Treatment and prevention of mania associated with bipolar disorders. i) Adults: Dosage should start at 500mg daily increasing by 200mg at three-day intervals until control is achieved. This is generally within the dosage range 1000mg to 2000mg per day. Children: >20KG: 500mg/day (irrespective of weight) with spaced increases until control is achieved. ii) Initial dose of 1000mg/day, to be increase rapidly as possible to achieve lowest therapeutic dose, which produce desired clinical effects. Recommend initial dose is 1000mg & 2000mg daily. Max dose 3000mg daily.

Halaman-halaman